Different types of intranasal steroids for chronic rhinosinusitis.

@article{Chong2016DifferentTO,
  title={Different types of intranasal steroids for chronic rhinosinusitis.},
  author={Lee Yee Chong and Karen Head and Claire Hopkins and Carl M. Philpott and Martin J. Burton and Anne G M Schilder},
  journal={The Cochrane database of systematic reviews},
  year={2016},
  volume={4},
  pages={
          CD011993
        }
}
BACKGROUND This review is one of six looking at the primary medical management options for patients with chronic rhinosinusitis.Chronic rhinosinusitis is common and is characterised by inflammation of the lining of the nose and paranasal sinuses leading to nasal blockage, nasal discharge, facial pressure/pain and loss of sense of smell. The condition can occur with or without nasal polyps. Topical (intranasal) corticosteroids are used with the aim of reducing inflammation in the sinonasal… 

Figures from this paper

Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.

The effects of intranasal corticosteroids in people with chronic rhinosinusitis were assessed, disease-specific health-related quality of life (HRQL), patient-reported disease severity and the commonest adverse event - epistaxis.

Systemic and topical antibiotics for chronic rhinosinusitis.

The primary outcomes were disease-specific health-related quality of life (HRQL), patient-reported disease severity and the commonest adverse event - gastrointestinal disturbance and it is very uncertain if antibiotics were associated with an increase in gastrointestinal disturbances.

Topical and systemic antifungal therapy for chronic rhinosinusitis.

The main outcomes were disease-specific health-related quality of life, patient-reported disease severity and the significant adverse effects of hepatic toxicity (systemic antifungals), and the quality of the evidence for each outcome.

Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.

A short course of oral corticosteroids as an adjunct ('add-on') therapy in people with chronic rhinosinusitis who are already on standard treatments and there was a greater improvement in symptom severity 30 days after the start of treatment in patients who received oral steroids and antibiotics.

Saline irrigation for chronic rhinosinusitis.

The effects of saline irrigation in patients with chronic rhinosinusitis was evaluated and the evidence was assessed to be of low quality for the three months follow-up and very lowquality for the six months following-up.

Biologics for chronic rhinosinusitis.

This living systematic review is one of several Cochrane Reviews evaluating the medical management of patients with chronic rhinosinusitis and three biologics, with different targets, were evaluated: dupilumab, mepolizumAB and omalizumab.

Biologics for chronic rhinosinusitis.

This living systematic review is one of several Cochrane Reviews evaluating the medical management of patients with chronic rhinosinusitis and found dupilumab may result in a reduction in serious adverse events compared to placebo, while omalizumab probably results in a large reduction in disease severity.

Safety review of current systemic treatments for severe chronic rhinosinusitis with nasal polyps and future directions

Antibiotics are commonly prescribed in nasal polyposis although there is also very little evidence for their use outside of acute infection and studies suggest that any benefit is lost within weeks of finishing treatment.

Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial

The comparative effectiveness of endoscopic sinus surgery (ESS) or a prolonged course of antibiotics (clarithromycin) in adult patients with CRS in terms of symptomatic improvement and costs to the National Health Service compared with standard medical care at 6 months is established.

Nasal steroid use and osteitis development in chronic rhinosinusitis with nasal polyps

A positive high correlation was found between the severity of GOS and NSU, and the value of the NSU effect in the development of osteitis is questioned, but the presence of NSU should be investigated in future histopathological studies.
...

References

SHOWING 1-10 OF 77 REFERENCES

Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.

The effects of intranasal corticosteroids in people with chronic rhinosinusitis were assessed, disease-specific health-related quality of life (HRQL), patient-reported disease severity and the commonest adverse event - epistaxis.

Systemic and topical antibiotics for chronic rhinosinusitis.

The primary outcomes were disease-specific health-related quality of life (HRQL), patient-reported disease severity and the commonest adverse event - gastrointestinal disturbance and it is very uncertain if antibiotics were associated with an increase in gastrointestinal disturbances.

Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.

A short course of oral corticosteroids as an adjunct ('add-on') therapy in people with chronic rhinosinusitis who are already on standard treatments and there was a greater improvement in symptom severity 30 days after the start of treatment in patients who received oral steroids and antibiotics.

Saline irrigation for chronic rhinosinusitis.

The effects of saline irrigation in patients with chronic rhinosinusitis was evaluated and the evidence was assessed to be of low quality for the three months follow-up and very lowquality for the six months following-up.

Topical steroid for chronic rhinosinusitis without polyps.

A meta-analysis of symptom improvement data revealed more benefit when steroid was administered directly to the sinuses than with simple nasal delivery, and topically administered corticosteroid may be included in a comprehensive treatment of CRS without polyps.

Topical steroids for nasal polyps.

Topical corticosteroids are a beneficial treatment for Chronic rhinosinusitis with nasal polyps and the adverse effects are minor, with benefits outweighing the risks.

Sinusitis in an allergist's office: analysis of 200 consecutive cases.

The findings indicate that medical management of chronic sinusitis in an allergist's office is effective, and the most common presenting symptoms were nasal congestion, postnasal drip, and purulent rhinorrhea.

European Position Paper on Rhinosinusitis and Nasal Polyps 2012.

The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of similar evidence based position papers published in 2005 and 2007 and contains chapters on definitions and classification and management schemes based on the evidence are proposed.

European position Papaer on Rhinosinusitis and Nasal Polyp 2007

The anatomy and (patho)physiology, epidemiology and predisposing factors, inflammatory mechanisms, evidence based diagnosis, medical and surgical treatment in acute and chronic rhinosinusitis and nasal polyposis in adults and children are described.
...